Schunk GL, Lehman WL. Mongolism and congenital leukemia . JAMA . 1954;;155:250-251.
Granick DJ. Hematological changes in Down's syndrome . Crit Rev Oncol Hematol . 1986;;6:55-69.
Van Eyes J, Flexner JM. Transient spontaneous remission in a case of untreated congenital leukemia . AJDC . 1969;;118:507-510.
Lampkin BC, Peipon JJ, Price JK, Bove KE, Srivastava AK, Jones MM. Spontaneous remission of presumed congenital acute nonlymphoblastic leukemia (ANLL) in a karyotypically normal neonate . Am J Pediatr Hematol Oncol . 1985;;7:346-351.
Weinberg AG, Schiller G, Windmiller J. Neonatal leukemoid reaction: an isolated manifestation of trisomy 21 . AJDC . 1982;;136:310-311.
Heaton DC, Fitzgerald PH, Fraser GJ, Abbot GD. Transient leukemoid proliferation of the cytogenetically unbalanced +21 cell line of a constitutional mosaic boy . Blood . 1981;;57:883-887.
Hanna MD, Melvin SL, Dow LW, Williams D, Dahl G, Mirro J. Transient myeloproliferative syndrome in a phenotypically normal infant . Am J Pediatr Hematol Oncol . 1985;;7:79-81.
Seibel NL, Sommer A, Miser J. Transient neonatal leukemoid reactions in mosaic trisomy 21 . J Pediatr . 1984;;104:251-254.
Brodeur GM, Dahl GV, Williams DL, Tipton RE, Kalwinsky DK. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn . Blood . 1980;;55:691-693.
Ferster A, Verhest A, Vamos E, de Maertelaere E, Otten J. Leukemia in a trisomy 21 mosaic: specific involvement of the trisomic cells . Cancer Genet Cytogenet . 1986;;20:109-113.
Waggoner DD. Origin of Human Trisomy 21 Mosaicism. Portland, Ore: Portland State University; 1984. Thesis.
Segal GM, McCall E, Bagby GC. Erythroid burst-promoting activity produced by interleukin-1-stimulated endothelial cells is granulocyte-macrophage colony-stimulating factor . Blood . 1989;; 72:1364-1367.
Raskind WH, Disteche CM, Keating A, Singer JW. Correlation between cytogenetic and molecular findings in human chronic myelogenous leukemia lines EM-2 and EM-3 . Cancer Genet Cytogenet . 1987;;25:271-284.
Rowley JD. Down syndrome and acute leukemia: increased risk may be due to trisomy 21 . Lancet . 1980;;2:1020-1022.
Wong KY, Jones MM, Srivastava AK, Gruppa RA. Transient myeloproliferative disorder and acute non-lymphoblastic leukemia in Down syndrome . J Pediatr . 1988;;112:18-22.